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ABSTRACT 
Objective: The present study was aimed to investigate the antidiabetic activity of ethanolic and aqueous extract of Zanthoxylum ovalifolium on 
alloxan induced diabetic rat model in rats. 
Methods: The leaves of Zanthoxylum ovalifolium were evaluated for antidiabetic activity by using alloxan induced diabetic model in diabetic rats. 
Diabetes was induced by single intraperitoneal injection of alloxan (100 mg/kg) and rats were treated orally with test extracts, standard drug 
(glibenclamide 5 mg/kg) and vehicle for 21 d. The hypoglycemic effects and lipid profile of diabetic rats were assessed using diagnostic kits. Finally, 
histopathological studies were carried out for pancreas. 
Results: The acute toxicity studies revealed at the dose of 2000 mg/kg (b. w) of Zanthoxylum ovalifolium for ethanol and aqueous extract were 
found to be safe. A significant reduction (p<0.001) in blood glucose was observed in diabetic rats treated with different doses of extracts compared 
to untreated diabetic rats. The drug possesses a good hyperlipidemic effect by normalizing the lipid parameters. This was evidenced by 
histopathological studies; both glibenclamide and 400 mg/kg of Ethanolic extract does appear to be regulated diabetes at the cellular level, resulting 
in the restoration of near normal architecture pancreatic islet of langerhans. 
Conclusion: It can be concluded from our research findings that ethanolic and aqueous extract of Zanthoxylum ovalifoliumat high dose (400 mg/kg) 
exhibited significant antihyperglycemic activity than extract at low dose (200 mg/kg) in alloxan induced diabetic rats. These extracts also showed 
improvement in parameters like lipid profile as well as regeneration β-cells in the pancreas and so might be of value in diabetes treatment. 
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INTRODUCTION 
Diabetes mellitus is a heterogeneous metabolic disorder 
characterized by the common feature of chronic hyperglycemia with 
disturbance in carbohydrate, fat and protein metabolism [1]. It 
defects in insulin secretion, insulin action or both [2]. Diabetes 
mellitus is represented by hyperglycemia, lipidaemia and oxidative 
stress [3]. It is recognized as a major global chronic health problem, 
accounting for significant morbidity and mortality; it is associated 
with microvascular (retinopathy, neuropathy and nephropathy) and 
macrovascular (heart attack, stroke and peripheral vascular disease) 
complications [4]. The International Diabetes Federation (IDF) 
estimates that in 2013, the number of people suffering from diabetes 
was 382 million, while 5.1 million died, and that this prevalence will 
rise to 592 million by 2035 [5]. Though there are several synthetic 
drugs available for reducing the blood glucose levels, such as 
sulfonylurea, biguanide, thiazolidinedione, α-glucosidase inhibitors, 
and glinides. Patients continue to suffer from the several adverse 
effects of these synthetic drugs due to which, to explore a for new 
herbal drug is going on and concerted efforts are being made to 
develop suitable alternative effective remedies for diabetes [6, 7]. 
Presently, there is a growing interest in herbal remedies that are 
apparently efficient, produce minimal side effects, and are rich 
sources of antidiabetic, antihyperlipidemic and antioxidant agents 
such as flavonoids, tannins and other related polyphenols [8]. 
The Zanthoxylum ovalifolium has been widely used for traditional 
medicine in various types of illness. These plants are deciduous 
shrub and trees belonging to the family Rutaceae, which consists of 
250 species native to subtropical regions of the world [9]. The genus 
is rich source of various chemicals such as alkaloids, glycosides, 
flavanoids, phenols, steroids, tannins, terpenes and amides etc. [10]. 
Information provided by traditional healers in the Western Ghats 
indicates that the leaf of Zanthoxylum ovalifolium is used to treat 
diabetes and hypertension. However, there is a lack of sufficient 
scientific data proving the traditional use of Zanthoxylum ovalifolium 
in the treatment of diabetes. Hence there is an increasing need of a 
new natural antidiabetic agent with less adverse effects; safe and 
easily available. So, the present investigations were undertaken to 
evaluate the effects of the ethanolic and aqueous extracts resulting 
in antidiabetic activity in alloxan-induced diabetes in rats. 
MATERIALS AND METHODS 
Plant material 
The leaves of Zanthoxylum ovalifolium were collected from the 
Agumbe village of Thirthahalli Taluk, Shivamogga district of 
Karnataka and were authenticated by Dr. Rudrappa, Professor and 
H. O. D Dept. of Botany, S. R. N. M National College of Applied Science, 
Balraj Urs road, Shivamogga, Karnataka state. A voucher specimen of 
the plant was preserved in the herbarium (Specimen No. 506/2016-
17) deposited in the Pharmacognosy Department, National College 
of Pharmacy, Shivamogga for further reference. 
Preparation of the extracts 
The leaves of Zanthoxylum ovalifolium were cleaned and dried under 
shade at room temperature for several days and coarsely powdered. 
The powdered material was extracted successively with different 
solvents viz. Petroleum ether, ethanol in a Soxhlet extractor for 48 h 
in 4 batches of 50 each. The extract was concentrated in a vacuum 
using rotary flash evaporator (Buchi, Flawil, Switzerland). The marc 
obtained after ethanolic extraction is kept in contact with distilled 
water for 48 h with occasional shaking in the stoppered container 
for cold maceration process. The extract is concentrated under 
reduced pressure and stored in a refrigerator for further use. 
Experimental animals 
Healthy wistar albino rats of either sex weighing about 200-250g 
were selected in the present experimental study. The animals were 
procured from Central Animal House, National College of Pharmacy, 
Shivamogga. After randomization into various groups, animals were 
acclimatized for a period of 10 d under standard husbandry 
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conditions. The rats were fed with a standard pellet diet and water 
ad libitum. The experimental protocol was approved by the 
Institutional Animal Ethical Committee (IAEC) of National College of 
Pharmacy, Shivamogga, Karnataka (Approval No. NCP/IAEC/ 
CL/06/2016-17) and care of the animals was taken as per guidelines 
of the CPCSEA. 
Chemicals 
Alloxan and glibenclamide were purchased from Sigma-Aldrich and 
Sun Pharmaceuticals, respectively. All other reagents used during 
the experiments were of analytical grade. 
Phytochemical analysis 
Preliminary phytochemical studies of both the extracts were 
performed as per standard procedure [11, 12]. 
Acute toxicity test  
A preliminary toxicity study was conducted to demonstrate the 
appropriate safe dose range that could be used for subsequent 
experiments rather than to provide complete toxicity data on the 
extract. Acute toxicity studies conducted revealed that the 
administration of the ethanolic and aqueous extract (up to a dose 
of 2000 mg/kg) of Zanthoxylum ovalifolium leaves did not produce 
significant changes in behavior of the animals. No death was 
observed up to the dose of 2000 mg/kg b.w. The rats were 
physically active. These effects were observed during the 
experimental period (14 d). The results showed that in a single 
dose the plant extract had no adverse effect, indicating that the 
medium lethal dose (LD50) could be greater than 2000 mg/kg 
body weight in rats. In the acute toxicity study, no toxic symptoms 
were observed for Zanthoxylum ovalifolium up to the dose of 2 
g/kg body weight. All animals behaved normally. No neurological 
or behavioral effects could be noted. No mortality was found up to 
14 d study
Induction of diabetes and experimental design 
 [13]. 
After fasting, hyperglycemia was induced by i. p. injection of 100 
mg/kg of alloxan monohydrate in sterile saline administered for 
induction of diabetes in rats [14]. After 1h of alloxan administration, 
the animals were fed standard pellets and water ad libitum. The rats 
were then kept for the next 24hours on 10% fructose solution 
bottles in their cages to prevent hypoglycemia. After 72hr of 
Injection, fasting blood glucose levels are estimated. Rats showing 
fasting blood glucose level of more than 200 mg/dl were considered 
as diabetic and selected for the study [15]. 
The experiments were conducted on animal groups to see the effect 
of Zanthoxylum ovalifolium leaves on diabetic rats. Six rats were 
used in each of the seven groups, which were as follows 
The animals were divided into seven groups of six animals each as 
follows. 
Group I: Normal control rats treated with vehicle 0.5 ml of 5% tween 
80  
Group II: Diabetic control received vehicle  
Group III: Diabetic rats treated with standard drug glibenclamide (5 
mg/kg b. w.). 
Group IV and Group V: diabetic rats treated with EEZO (200 mg and 
400 mg/kg b. w.), respectively 
Group VI and Group VII: diabetic rats treated with AEZO (200 mg 
and 400 mg/kg b. w.) respectively. The vehicle, EEZO, AEZO and 
glibenclamide were administered once daily for 21 d from the day of 
induction. 
Blood glucose estimation 
Blood was drawn from tip of the tail, and blood glucose level was 
estimated at0, 7th, 14th and 21st day of the experiment with the help 
of a glucometer (GluNEO® Lite (INFOPIA Co Ltd) using the strip 
method. On the 21st
Histopathological study  
 day, the blood sample was collected by 
puncturing retro-orbital plexus and serum was separated by 
centrifugation for measuring total cholesterol (TC), triglycerides 
(TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) 
and very-low-density lipoprotein (VLDL) levels were evaluated in all 
groups using an auto-analyzer (Semi-auto chemistry analyzer DIA 
SIL-100).  
Portions of the pancreas from all the experimental groups were 
fixed 10% formalin, dehydrated in alcohol and then embedded in 
paraffin. Microtome sections (5µ m thickness) were prepared from 
the Pancreas sample and stained with hematoxylin-eosin dye. The 
sections were examined for pathological studies. 
Statistical analysis 
The results are expressed as mean±standard error mean (SEM). The 
results were analyzed by one-way ANOVA followed by Tukey’s 
multiple range test using graph pad prism 3.10 versions values<0.05 
were considered as statistically significant. 
RESULTS 
Preliminary phytochemical analysis 
The preliminary phytochemical analysis reveals that triterpenoids, 
flavonoids, steroids, glycosides, alkaloids and tannins were present 
in the ethanolic extract. In the aqueous extract, saponins, flavonoids 
and alkaloids are present. 
Acute toxicity test 
In acute toxicity studies of ethanolic and aqueous extract of 
Zanthoxylum ovalifolium leaves does not show mortality of animals 
at the dose level of 2000 mg/kg. Therefore 2000 mg/kg dose was 
considered as a LD50.  Hence, in the present study 200 mg/kg (1/10th 
low dose) and 400 mg/kg (1/5th
Effect on blood glucose level 
 high dose) body weight doses were 
selected for the antidiabetic study. 
The effect of Zanthoxylum ovalifolium leaf extracts on blood glucose 
level in alloxan-induced diabetes in rats is given in table 1. The blood 
glucose level was increased significantly in alloxan-induced diabetic 
rats as compared with the control rats. In diabetic rats, a significant 
decrease in blood glucose level was observed after the treatment 
with different extracts. The ethanolic and aqueous extract of 
Zanthoxylum ovalifolium showed maximum antidiabetic potential at 
21st
Effect on lipid profile 
 day treatment; however, these extracts exhibited antidiabetic 
activity in dose and time-dependent manner. 
When compared to the normal control group, the serum TC, TG, LDL 
and VLDL cholesterol levels were increased, whereas the level of 
HDL cholesterol was reduced by in untreated diabetic rats in table 2. 
After treatment of ethanolic and aqueous extract of Zanthoxylum 
ovalifolium for 21 d, the serum TC, TG, LDL and VLDL cholesterol 
level were reduced significantly, whereas the level of serum HDL 
cholesterol was significantly increased in time and dose-dependent 
fashion. 
Histopathological study of rat pancreas 
The microscopic structures of rat pancreas in different groups are 
shown in fig. 1. The pancreas of a normal control rats showed 
normal islets and pancreatic β-cells; however, in diabetic control 
rats, the islets are disrupted islet of langerhans exhibited 
hydrophobic cells, necrotic cells, vacuolization and irregular 
hyperchromic nuclei. The ethanolic extract of Zanthoxylum 
ovalifolium at the dose of 400 mg/kg b. w. shows a more 
regeneration of β-cells in the histopathological slides when 
compared to EEZO 200 mg/kg, AEZO 200 mg/kg and AEZO 400 
mg/kg.
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Table 1: Effect of Zanthoxylum ovalifolium leaf extracts on blood sugar level in alloxan-induced diabetes in rats 
Treatment Dose 
mg/kg 
 Blood glucose (mg/dl) 
0th 7 d th 14 d th 21d th d 
Normal control - 101.11±1.36 104.4±1.60 108.56±0.62 106.43±2.08 
Diabetic control  346.23±3.64 361.43±3.62 372.66±3.13 381.50±1.84 
Glibenclamide 5 334.70±1.59 260.26±1.33 143.83±1.99 123.50.5±1.06 
EEZO 200 333.10±2.72 272.52±2.16 ns 206.40±1.75** 145.00±0.99* 
EEZO 400 327.33±0.91 277.26±5.12** ns 224.41±1.48*** 136.10±0.77*** 
AEZO 200 341.75±2.39 286.18±1.72 ns 233.66±1.35* 166.5±0.76* 
AEZO 400 331.17±1.65 279.78±2.08* ns 232.36±2.14* 152.88±1.86*** 
Data are expressed as mean±SEM; n=6. One-way ANOVA followed by Tukey’s multiple comparison test when compared with normal control, 
*p<0.05, **p<0.01, ***p<0.001 significant. 
 
Table 2: Effect of Zanthoxylum ovalifolium on serum lipid profile in diabetic rats 
Treatment Dose mg/kg TC TG HDL LDL VLDL 
Normal control - 81.2±1.03 72.0±1.20 39.4±0.90 45.4±1.50 15.9±1.46 
Diabetic control - 179.4±1.03 145.2±0.81 28.9±1.47 188.7±0.85 32.8±0.91 
Glibenclamide 5 125.1±0.96 114.8±1.65 36.6±1.06 109.4±1.47 30.4±1.53 
EEZO 200 88.8±1.07** 77.6±077* 46.8±1.20** 51.6±0.68* 22.5±0.77** 
EEZO 400 88.7±1.77** 90.0±1.20*** 53.5±1.67*** 53.5±1.66** 27.9±1.23*** 
AEZO 200 88.6±1.15** 78.9±0.95** 42.8±1.04 52.8±1.58** 21.3±1.22* 
AEZO 400 88.8±0.98** 87.5±0.97*** 46.0±1.63* 59.0±1.22*** 23.4±0.72** 
Data are expressed as mean±SEM; n=6. One-way ANOVA followed by Tukey’s multiple comparison test when compared with normal control, 
*p<0.05, **p<0.01, ***p<0.001 significant. 
 
 
Fig. 1: Histopathology of pancreas in alloxan-induced diabetic rats. A. Control group showing the normal architecture of the pancreas. The 
exocrine constituent systems of pancreas closely packed by acinar  cells and arranged into small lobules. Pancreatic lobules detached by 
intactintra lobular  and inter lobular  connective tissue septa. The islet cells are seen interspersed between the acinar  cells. The islets appeared 
lightly stained than the surrounding acinar  cells. B. Diabetic rats revealed pathological changes of both exocrine and endocr ine components. 
Theacinar  cells were swollen and small vacuoles were observed in almost all acinar  cells. Inter lobular  ducts were lined with flattened epithelium 
(indicated by black tr iangle). Islet β-cells are almost fully lost in alloxanmonohydrate treated rats. C. Diabetic rats treated with Glibenclamide (5 
mg/ kg) showing distor tion of the general architecture. Most exocrine acini revealed acinar  damage represented by cytoplasmic vacuolation and 
cell atrophy (indicated by black tr iangle). Wider  inter lobular  (marked by black arrow) and intralobular  (marked by black star) duct was 
observed. D. Diabetic rats treated with EEZO (200 mg/ kg) displaying near ly normal structure of Islets of Langerhans. Atrophic change of the 
acinar  cells was less severe and the border  between exocrine and endocrine por tions became more distinct. E. Diabetic rats treated with EEZO 
(400 mg/ kg) shown rejuvenation of islets. The small vacuoles in the basal area of acinar  cells were also much smaller . F. Diabetic rats treated with 
AEZO (200 mg/ kg) shown rejuvenation of islets. The small vacuoles in the basal area of acinar  cells were also much smaller . G. Diabetic rats 
treated with AEZO (400 mg/ kg) shown displaying the near ly normal structure of Islets of Langerhans. Atrophic change of the acinar  cells was 
comparatively severe and the border  between exocrine and endocr ine portions became more distinct 
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DISCUSSION 
The various numbers of plants have been traditionally used to treat 
diabetes and some have been proven to have hypoglycemic effects. 
These studies have identified that compounds such as 
polysaccharides [16], flavonoids [17], terpenoids and tannins [18] 
and steroids [19] are responsible for the antidiabetic effect. The 
Zanthoxylumovalifolium 
Alloxan is one of the usual substances used for the induction of 
diabetes mellitus apart from streptozotocin. Alloxan has a 
destructive effect on the beta cells of the pancreas [20, 21]. Alloxan 
causes a massive reduction in insulin release by the destruction of β-
cells the islets of langerhans, thereby inducing hyperglycemia. 
Insulin deficiency leads to various metabolic alterations in the 
animals viz increased blood glucose, increased cholesterol, 
increased levels of alkaline phosphate and transaminases [22-24]. 
also contains flavonoids, saponins and 
carbohydrate, steroids, tannins, and phenolic compounds. The 
observed hypoglycemic effects of this plant could have resulted from 
the combined activity of these compounds present in the extract. 
The ethanol and aqueous extract of Zanthoxylum ovalifolium was 
found to be effective in normalizing the elevated levels of blood 
glucose and blood lipid-like cholesterol, triglycerides, LDL and VLDL. 
Administration of alloxan (100 mg/kg i. p) led to an elevation of 
fasting blood glucose levels, which was maintained throughout the 
period of 21 d of daily treatment of EEZO and AEZO led to a fall in 
blood sugar levels. In our studies, the disruption of pancreas in 
alloxan treated diabetic control rats [fig. 1(B)] and regeneration of 
cells by glibenclamide [fig. 1(C)] was observed. It is found that 
ethanol and aqueous extract at high dose (400 mg/kg) is more 
effective than extract at low dose (200 mg/kg) of 21th
Histopathological examination (fig. 1) of the pancreas, in the normal 
control group, the section of pancreas showing well compacted, 
arranged in cord like manner the cell of endocrine pancreas 
especially the β-cells in the center and alpha in the periphery no 
necrosis were observed. After inducing alloxan, in diabetic control 
group the islets are disrupted islets of langerhans exhibited 
hydrophobic cells, necrotic cells, vacuolization and irregular 
hyperchromic nuclei. Regeneration of cells can be observed in 
standard drug (glibenclamide) treated group. In the ethanolic 
extract of Zanthoxylum ovalifolium (200 mg/kg) showing necrotic β-
cells and congestive changes with loss of cytochromic granules. The 
well-formed compactly arranged β-cells surrounded by alpha cells 
also note the presence of small highlight indicative of regeneration 
has been observed in the ethanolic extract of Zanthoxylum 
ovalifolium (400 mg/kg). In aqueous extract of Zanthoxylum 
ovalifolium (200 mg/kg) the islet of langerhans showing on set of 
necrotic changes in some of the β-cells also note the granular 
cytoplasm indicating presence of insulin granules. The Presence of 
small highlight and pancreatic duct in the adjacent area indication of 
ductular hyperplasia and regeneration has been observed in 
aqueous extract of Zanthoxylum ovalifolium (400 mg/kg). 
 day treatment. 
The ethanolic and aqueous extract at high dose (400 mg/kg) is more 
effective and shows similar curative effect as the standard that is 
glibenclamide (5 mg/kg). This could be due to the possibility that 
some cells are still surviving to act upon by Zanthoxylum ovalifolium 
extract to exert its insulin-releasing effect. 
CONCLUSION 
It can be concluded from the present investigations that ethanol and 
aqueous extracts of Zanthoxylum ovalifolium at high dose (400  mg/kg) 
exhibited significant antihyperglycemic activity than at low dose 
(200 mg/kg) in alloxan-induced diabetic rats. These test extracts also 
showed improvement in parameters like lipid profile as well as 
regeneration of cells in the pancreas. However, further studies are 
needed to investigate and elucidate the possible mechanism of action 
of the active ingredients, establish complete safety profiles and 
evaluate the potential value of Zanthoxylum ovalifolium leaf extracts 
for the management of diabetes and hyperlipidemia. 
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